Pharmaceutical industry opportunities at the Mexican Genomic Medicine Institute;Oportunidades para la industria farmacéutica en el Instituto de Medicina Genómica de México

Gaceta Medica de Mexico

Volumn 138, Issue 3, 2002, Pages 291-294

  Jiménez Sánchez, Gerardo ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Departamento 101   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; GENOMICS; HEALTH CARE ORGANIZATION; HUMAN; HUMAN GENOME; MEDICAL GENETICS; MEXICO; PHARMACOGENETICS; PHARMACOGENOMICS; REVIEW;

ACADEMIES AND INSTITUTES; DRUG INDUSTRY; FORECASTING; GENOME, HUMAN; GENOMICS; HUMANS; MEXICO; PHARMACOGENETICS;

EID: 0036089034     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Human disease genes
4. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
5. 1998 ASHG Presidential Address. Making genomic medicine a reality
6. Implicaciones médicas y sociales del genoma humano en la sociedad mexicana
7. La medicina genómica: Un nuevo paradigma en el cuidado de la salud
8. The essence of SNPs
9. Pharmacogenomics: Translating functional genomics into rational therapeutics
10. Pharmacogenetics and the practice of medicine
11. Pharmacogenetics
12. Population genetic structure of variable drug response
13. Population genomics: Linkage disequilibrium holds the key
14. Development of the first center for genomic medicine in Mexico